Lilly signals aesthetics push and launches LillyDirect in Australia
· Health · United States · Australia
Eli Lilly is looking to enter the aesthetics business and acquire drugs for skin aging, skin diseases, body shape and hair conditions, according to a new job posting. Separately, Lilly is launching LillyDirect in Australia to deliver Mounjaro directly to patients, bypassing local pharmacies and drawing criticism from doctors and pharmacists.
Why it matters:Lilly is extending its metabolic franchise into new categories and new distribution models, which could pressure pharmacy channels and push rivals toward similar direct-to-patient strategies.
Key points
- A job posting indicates Lilly plans to acquire drugs in skin aging, body shape and hair.
- LillyDirect will ship Mounjaro straight to Australian patients' doors.
- Local Australian doctors and pharmacists are unhappy with the bypass of pharmacies.
Sources (original reporting)
More stories from this day
- Summit partners with AstraZeneca and Daiichi on cancer drug trial
- Anthropic Reportedly Eyes Mid-November IPO
- Weak September Jobs Report Sinks Fed Rate Hike Odds
- $50bn South Korean investment pushes Alaska LNG toward construction
- US rolls back fuel economy rules and farmer solar grants
- Tesla Q3 deliveries fall 2% but beat estimates